ATRX and breast cancer: In order to verify the role of ATRX in the first-line drugs sensitivity to HER2-/HR+ BC, the half maximal inhibitory concentration (IC50) of PTX, DOX and TMX on MCF-7 cell and MCF-7 cell with lentivirus-mediated ATRX overexpression were detected.